PT Jayamas Medica Industri Tbk (IDX: OMED)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
181.00
+2.00 (1.12%)
Sep 10, 2024, 3:48 PM WIB

OMED Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
1,805,2961,736,9901,739,0542,226,5731,994,5401,228,049
Revenue Growth (YoY)
3.93%-0.12%-21.90%11.63%62.42%-
Cost of Revenue
1,225,2621,185,0561,176,0451,322,544957,599782,576
Gross Profit
580,034551,934563,010904,0301,036,940445,473
Selling, General & Admin
255,159250,002198,309168,243186,715149,961
Other Operating Expenses
3,6111,057-7,5422,951736.383,335
Operating Expenses
258,682251,059190,767171,194187,451153,295
Operating Income
321,352300,875372,243732,836849,489292,178
Interest Expense
-19,761-19,581-20,805-21,840-9,008-384.94
Interest & Investment Income
51,77043,52014,37116,90914,94510,157
Currency Exchange Gain (Loss)
17,7481,6546,7041,4455,821185.87
Other Non Operating Income (Expenses)
-397.11-341.03-403.98-328.64-149.77-146.62
EBT Excluding Unusual Items
370,712326,127372,109729,020861,098301,989
Gain (Loss) on Sale of Assets
-101.635.590.04179.92583.7297.57
Pretax Income
370,611326,162372,109729,200861,681302,287
Income Tax Expense
76,04065,18081,602158,821168,81274,262
Earnings From Continuing Operations
294,571260,982290,507570,379692,869228,024
Minority Interest in Earnings
-1,874-1,622-4,725-7,687-7,359-1,816
Net Income
292,696259,360285,782562,692685,510226,208
Net Income to Common
292,696259,360285,782562,692685,510226,208
Net Income Growth
7.67%-9.25%-49.21%-17.92%203.04%-
Shares Outstanding (Basic)
27,05927,05927,05927,05927,45551,111
Shares Outstanding (Diluted)
27,05927,05927,05927,05927,45551,111
Shares Change (YoY)
-6.98%---1.44%-46.28%-
EPS (Basic)
10.829.5910.5620.8024.974.43
EPS (Diluted)
10.829.5910.5620.8024.974.43
EPS Growth
15.75%-9.25%-49.21%-16.72%464.16%-
Free Cash Flow
283,516-22,03117,549422,386228,771160,224
Free Cash Flow Per Share
10.48-0.810.6515.618.333.13
Dividend Per Share
2.8806.050-10.87017.000-
Dividend Growth
-9.15%---36.06%--
Gross Margin
32.13%31.78%32.37%40.60%51.99%36.27%
Operating Margin
17.80%17.32%21.40%32.91%42.59%23.79%
Profit Margin
16.21%14.93%16.43%25.27%34.37%18.42%
Free Cash Flow Margin
15.70%-1.27%1.01%18.97%11.47%13.05%
EBITDA
361,375335,378392,559752,142864,958305,786
EBITDA Margin
20.02%19.31%22.57%33.78%43.37%24.90%
D&A For EBITDA
40,02334,50420,31719,30715,46913,608
EBIT
321,352300,875372,243732,836849,489292,178
EBIT Margin
17.80%17.32%21.40%32.91%42.59%23.79%
Effective Tax Rate
20.52%19.98%21.93%21.78%19.59%24.57%
Source: S&P Capital IQ. Standard template. Financial Sources.